Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Patent
1994-08-11
2000-03-21
Burke, Julie
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
514 12, 514 13, 530300, 530324, 530325, 530326, A61K 3900, A61K 3817, C07K 708, C07K 1447
Patent
active
060399473
ABSTRACT:
Peptides containing immunodominant epitopes of myelin basic protein that are recognized by groups of T-cells from remitting-relapsing multiple sclerosis patients.
REFERENCES:
patent: 4634590 (1987-01-01), Cohen et al.
Higgins et al., J. Immunology, 140:440-445, 1988.
Eylar, Adv. Exp. Med. Bio., 98:259-281, 1978.
Sriram et al., Cell Immunol., 75:378-382, 1983.
Nagler-Anderson et al., PNAS, 83:7443-7446, 1986.
Schoen, J. Immunol., 128:717-719, 1982.
Higgins et al., Annals Neurology, abstract No. P154, 1986.
Whitacre et al., 6th Int'l. Cong. Immunol., abstract No. 3.62.21, 1986.
Zamvil et al., Nature, 324:258-260, 1986.
Fritz et al., J. Immunol., 134:2328-2332, 1985.
Fritz et al., J. Immunol., 130:191-194, 1983.
Pettinelli et al., J. Immunol., 129:1209-1211, 1982.
Whitaker et al., J. Bio. Chem, 250:9106-9111, 1975.
Thompson et al., Clin. Exp. Immunol., 64:581-586, 1985.
Lider et al., J. Immunol., 142:748-752, 1989.
Friedman et al., PNAS, 91:6688-6692, 1994.
Bitar, dissertation entitled, The Suppressive Effects of Oral Myelin Basic Protein . . . , 1986.
Nagler-Anderson, dissertation entitled, Immunoregulation of an Exp. Model of Autoimmunity, 1986.
Rothbart, 1st Forum in Virology, pp. 518-520, 1986.
Bitar et al., Cell Immunol., 112:364-370, 1988.
Eylar et al., Neurochem. Research, 4:249-258, 1979.
Kagnoff, Oral Tolerance, pp. 248-269, 1982.
Mowat, Immunol. Today, 8:93-98, 1987.
Weiner et al., Science, 259:1321-1324, 1993.
Campbell et al, Arch. Neurol., 29:10-15, 1973.
Carnegie et al., Immunol., 19:55-63, 1970.
Fritz et al., J. Immunol., 130:1024-1026, 1983.
Hashim et al., Arch. Biochem. and Biophy., 156:287-297, 1973.
Adorini et al., Nature 342:800-2, 1989.
Allegretta, M., et al., Science, 247:718-721, 1990.
Avrilionis, K. and Boggs, J.M., J. Neuroimmunol. 35:201-10, 1991.
Ben-Nun, A., et al., J. Immunol., 129:303-308, 1982.
Blackman et al., Science 248:1335-41, 1990.
Burns, F.R., et al., J. Exp. Med., 169:27-39, 1989.
Buss et al., Cell 47:1071-77, 1988.
Cresswell, Nature 343:593-94, 1990.
DeFreitas et al., Proc. Natl. Acad. Sci. USA 83:2637-41, 1986.
Gaur et al., Science 258:1491-4, 1992.
Germain, Nature 344:19-22, 1990.
Guillet et al., Nature 324:260-62, 1986.
Guillet et al., Science 235:865-70, 1987.
Hodes et al., Science 246:1041-44, 1989.
Howell, M.D., et al., Science, 246:668-670, 1989.
Janeway, Nature 341:482-83, 1989.
Kaye et al., Nature 341:746-49, 1989.
Lider et al., Ann. N. Y. Acad. Sci., pp. 267-273, 1986.
MacDonald, Science 246:982, 1989.
Maritn, R., et al., J. Immunol. 145:540-8, 1990.
Martin, R., et al., J. of Exper. Med. 173:19-24, 1991.
Martin, R., et al., J. Immunol. 148:1359-1366, 1992.
Mokhtarian, F., et al., Nature, 309:356-358, 1984.
Nikolic-Zugic et al., Nature 344:65-67, 1990.
Ogasawara et al., Nature 325:450-52, 1987.
Oksenberg et al., Nature 345:344-46, 1990.
Ota, K, et al., Nature, 346:183-7, 1990.
Pette, M., et al., Proc. Natl. Acad. Sci., USA 87:7968-72, 1990.
Schwartz, Ann Rev. Immunol. 3:237-61, 1985.
Su, X., et al., J. Neuroimmunol. 34:181-190, 1991.
Vandenbark, A.A., et al., Nature 341:541-433, 1989.
Weiner et at., (Abstr) Neurology (Suppl. 1) 39:172, 1989.
Wucherpfenning, K.W. et al., Science 248:1016-9, 1990.
Zamvil, S. S., et al., Nature, 324:258-260, 1986.
Fujimani et al Science vol. 230:1043-45, 1985.
Uyemura et al J Neurobiology vol. 39:895, 1982.
Hruby et al J Neurochem vol. 44:637, 1985.
Jahnke et al Science vol. 229:282-284, 1985.
Martenson J Neurobiology vol. 40:951, 1983.
Livingstone et al Ann Rev Immunology vol. 5 477-501, 1987.
Hurtenbach et al J Ex Medicine vol. 177 1499-1504, 1993.
Bishopp BioWorld Today vol. 8 No. 92 pp. 1 and 3, May 1997.
Hafler David A.
Weiner Howard L.
AutoImmune Inc.
Burke Julie
LandOfFree
Peptides derived from immunodominant epitopes of myelin basic pr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides derived from immunodominant epitopes of myelin basic pr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides derived from immunodominant epitopes of myelin basic pr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-728076